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Edited by Hans-Dieter KlenkAbstract The crystallographic T =1 (pseudo T =3) icosahe-
dral symmetry of the human rhinovirus capsid dictates the
presence of 60 identical, symmetry related surface structures
that are available for antibody and receptor binding. X-ray
crystallography has shown that 60 individual very-low density
lipoprotein receptor (VLDLR) modules bind to HRV2. Their
arrangement around the ﬁvefold axes of the virion suggested that
tandem oligomers of such modules could attach simultaneously
to symmetry-related sites. By resolving virus particles carrying
various numbers of artiﬁcial recombinant concatemers of
VLDLR repeat 3 (V33333) by capillary electrophoresis and
extrapolation of the measured mobilities to that at saturation of
all binding sites, we present evidence for up to 12 molecules of
the concatemer to bind one single virion.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Human rhinoviruses (HRVs), main causative agents of
common cold infections, belong to the family of picornaviridae
[1]. They are composed of four individual capsid proteins,
VP1, VP2, VP3, and VP4, and a single stranded RNA genome
of messenger sense polarity with about 7100 bases. There are
60 copies of each of the VPs in one viral particle. These pro-
teins are arranged in a T ¼ 1, pseudo T ¼ 3 icosahedral sym-
metry. Whereas VP4 is a small (7 kDa), internal protein
residing close to the RNA, the remaining capsid proteins fold
into b-barrel structures with the connecting loops exposed at
the surface. The amino acid sequence of these loops is highly
variable giving rise to more than 100 antigenically distin-
guishable serotypes. These are divided into a minor (10 sero-* Corresponding author. Fax: +43-1-4277-9616.
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binding to members of the low-density lipoprotein receptor
(LDLR) family or to intercellular adhesion molecule 1
(ICAM-1), respectively [2]. Another more recent classiﬁcation
into genus A and B is based on sequence similarity [3].
The LDLR family comprises LDLR proper, the prototype of
the family, very-low density lipoprotein receptor (VLDLR), the
LDLR related protein (LRP) and a number of other endocytic
receptors with some also being involved in signal transduction
[4]. Minor group HRVs attach to LDLR, VLDLR, and LRP
for cell entry [5,6]. LDL-receptors are mosaic proteins that
most probably evolved from single modules and building
blocks. Their ligand-binding domains at the N-terminus are
composed of various numbers of ligand binding repeats or type
A modules, each about 40 amino acids in length, among them
six cysteines that are all engaged in disulﬁde bridges. This
structure is further stabilized by a Ca2þ ion chelated by an
acidic cluster that is composed from highly conserved aspartic
and glutamic acid residues. LDLR has seven such modules,
VLDLR has eight, and LRP has clusters of 2, 8, 10, and
11 ligand binding repeats. C-terminal to these domains are
sequences with similarity to the epidermal growth factor re-
ceptor, a b-propeller with YWTD motives, a more or less O-
glycosylated membrane proximal domain, a transmembrane
domain and a cytoplasmic tail with NPXY adapter binding
sequences [7] responsible for clathrin-mediated endocytosis [8].
In order to determine the binding site of these receptors on
the viral surface, we have previously constructed several forms
of truncated soluble receptors just containing the N-terminal
ligand binding domain or parts of it [9]. Using these bacterially
expressed derivatives of VLDLR, complexes with HRV2, a
prototype of the minor receptor group of HRVs, were as-
sembled and analyzed by cryo-electron microscopy and X-ray
crystallography [10–12]. The derived structures showed that
single V3 modules (repeat #3 of VLDLR) attached to the BC
and HI loop of VP1 close to the ﬁvefold axis of icosahedral
symmetry (see Fig. 5). This suggested the possibility of multi-
module attachment; the arrangement of the C- and N-termini
of the single modules is such as to evoke that more than one
module, when present within either the native receptor or
within artiﬁcial concatemers, might attach simultaneously to
more than one binding site. This was also suggested by theblished by Elsevier B.V. All rights reserved.
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derivatives upon concatenation of individual modules [12,13].
When incubated with virus prior to challenging HeLa cells,
soluble receptors attach to the virus, compete for the binding
sites on the cell surface and thereby protect the cells against
virus infection [14,15].
Wehavepreviouslydetermined the stoichiometry ofMBP-V1-
3 and of MBP-V1-8 when complexed with HRV2 and estimated
the aﬃnities of the binding reaction by capillary electrophoresis
(CE) [16]. These proteins are fusions of maltose binding protein
andparts (MBP-V1-3) and the entire (MBP-V1-8) ligandbinding
domain of VLDLR fused to maltose binding protein (MBP) at
the N-terminus, for better folding, and to a his tag, to aid puri-
ﬁcation, at the C-terminus [9]. For these receptors a stoichiom-
etry of 1:60 and 1:30, respectively, was found [16]. Since the
receptor-binding site was not known, this was taken to suggest
attachment of the receptor via a putative pseudo twofold axis
created by a kink in the structure [17] over a twofold symmetry
axis of the virus. The structures of complexes betweenHRV2and
a number of receptor fragments and artiﬁcial concatemers being
nowavailable [10], it is clear that the receptormodules bindat the
ﬁvefold axes of viral symmetry. In order to assess whether more
moduleswithin a single receptormolecule can attach to the virus,
we attempted to determine the stoichiometry of the reaction
between HRV2 and a concatemer of ﬁve copies of repeat 3
(MBP-V33333) of VLDLR by the same CE methodology.
During this work, we observed that, at low receptor: virus ratio,
CE resolved complexes with diﬀerent stoichiometry. At higher
ratios, the resolution diminished and at large excess of receptor,
single peaks, corresponding to the saturated complex and to free
receptor, were seen. The mobilities of the peaks decreased non-
linearly with an increase in viral occupancy. Nevertheless, ex-
trapolation to saturation was possible and a stoichiometry of 12
receptor molecules per virion was obtained.2. Materials and methods
2.1. Virus and receptor preparations
HRV2, originally obtained from the American Type Culture Col-
lection, Manassas, VA, USA, was produced and puriﬁed from infected
cell pellets as described previously [11]. Puriﬁed virus in the pellet
obtained after ultracentrifugation was suspended in 50 mM Tris–HCl,
pH 7.4, and kept at )80 C until use. The concentration was deter-
mined spectrophotometrically using an extinction coeﬃcient of 7.7 at
260 nm (A260) for a 1 mg/ml solution [18] corrected for contaminants
with absorption at 260 nm as identiﬁed by CE [19]. The virus batch
used in all experiments had a concentration of 5.4 mg/mL, i.e.,
6:75 107 M [20].
Concatemers of ﬁve copies of repeat 3 of the ligand binding domain
of VLDLR, fused to maltose binding protein (MBP) at the N-terminus
and to a his-tag at the C-terminus (MBP-V33333), were produced as
described [9,10,13]. Brieﬂy, the plasmid encoding MBP-V3 was cleaved
with SmaI to generate blunt ends at the 3’end of the sequence encoding
the VLDR-repeat. A fragment with the V3 coding sequence produced
by PCR was then ligated into this SmaI site. Analysis of the plasmids
recovered from transformed bacteria showed that concatemers with up
to four V3 modules arranged in tandem had formed. MBP-V3333 was
again digested with SmaI and ligated with a V3 fragment. From the
resulting higher order concatemers, MBP-V33333 was selected. The
concentration of puriﬁed MBP-V33333 used in all experiments was 0.2
mg/mL, corresponding to 29:6 107 M, as determined with the BCA
assay (Pierce, Rockford, IL, USA).
2.2. Complex formation
Virus was mixed with receptor at various molar ratios in sample
buﬀer (50 mM borate, pH 8.3). Five ll of HRV2 at 67.5 or 135 nMwas incubated with increasing amounts of MBP-V33333 (5 ll from 0 to
1.48 lM). Complex formation was allowed to occur during incubation
at room temperature for 1 h, then the sample was injected and the
components were separated by CE.2.3. Instrumentation
Capillary electrophoresis was performed with an automated HP3D
Capillary Electrophoresis System (Agilent, Waldbronn, Germany)
equipped with a diode array detector. An uncoated fused silica capil-
lary (Composite Metal Services Ltd., UK) with 60.0 cm total, 51.5 cm
eﬀective length, and 50 lm ID was used. The capillary was packed in a
standard HP cassette and thermostated to 20.0 C during all experi-
ments. Injection was at 450 mbar s, voltage was +25 kV. Data acqui-
sition, storage, and analysis were performed using Agilent
ChemStation Plus software. The background electrolyte (BGE) for CE
separation was 100 mM boric acid containing 10 mM SDS, adjusted to
pH 8.3 with 1 M NaOH. Complex formation was carried out in sample
borate buﬀer. o-Phthalic acid at 10 lg/ml was used as an internal
standard.3. Results
3.1. Capillary electrophoresis separation of virus–receptor
complexes
HRV2, at an initial concentration of 0:68 107 M in the
incubation mixture, was mixed at various ratios with MBP-
V33333, a recombinant concatemer of ﬁve copies of ligand
binding module 3 of VLDLR fused to maltose binding pro-
tein. After complex formation for 1 h at room temperature, an
aliquot was injected into the capillary and the components
were separated by CE. The control incubation, containing
virus only, gave rise to a single peak with a net mobility of
20:8 109 m2 V1 s1 (Fig. 1, panel A, and Table 1) that
roughly agrees with that determined previously for HRV2
[21]. When a mixture containing virus and receptor at a molar
ratio of 1:1.1 was analyzed (panel B), a series of peaks with
decreasing intensity at longer migration times, i.e., lower total
mobility, were seen. Note that this corresponds to a higher net
mobility as the anionic analytes migrate against the electro-
osmotic ﬂow directed towards the cathode. From comparison
with panel A, it is apparent that the ﬁrst main peak (indicated
by 0) represents the free virus. The other peaks were tenta-
tively identiﬁed as complexes with increasing numbers of re-
ceptor molecules bound per virus particle. The tracings
obtained at higher ratios of receptor to virus (panel C–G)
support this view. Finally, at an excess of receptor of 18 and
higher, a single peak, presumably the saturated virus–receptor
complex (indicated by ‘12’), appeared together with the peak
corresponding to excess receptor (MBP-V33333). This is
similar to earlier results with MBP-V1-3 and MBP-V1-8,
where the virus peak broadened and was shifted upon addi-
tion of receptor likely reﬂecting the presence of a population
of viral particles with diﬀerent receptor occupancy; at high
receptor to virus ratios, the peak became narrow again re-
ﬂecting the presence of a single species of virus–receptor
complex. In these previous experiments, no resolution of the
diﬀerent complexes was achieved [16]. This might be due to a
smaller diﬀerence in mobility or to lower aﬃnity leading to
partial dissociation during the CE run.
3.2. Electrophoretic mobilities of virus–receptor complexes
Upon increasingly higher occupancy, the net mobility of the
individual complexes increased (Table 1). It depends on the
Fig. 1. Capillary electropherograms of complexes between MBP-V33333 and HRV2. In traces A to F, HRV2 at a constant concentration of
0:68 107 M was incubated with increasing concentrations of receptor (0–7:4 107 M). Trace G depicts the result for a virus sample with
0:34 107 M concentration, and an 18-fold molar excess of MBP-V33333. Experimental conditions: uncoated fused silica capillary, 60.0/51.5 cm
length, 50 lm I.D.; detection at 200 nm. Voltage +25 kV. Injection 450 mbar s BGE: 100 mM borate buﬀer, pH 8.3, 10 mM SDS. The numbers of the
peaks indicate the occupancy with n ¼ 1; 2; 3; 4, etc. receptor fragments. 0: free virus. MBP-V33333: peak of free receptor. Numbers at the z-axis are
the initial molar ratios of virus to receptor in the incubation mixture. IS, internal standard, o-phthalic acid at 10 lg/mL.
Table 1
Net mobilities of virus-receptor complexes
Peak number 0 1 2 3 4 5 6 7 8 9 10 11 12
ln 20.82 22.28 23.43 24.36 25.11 25.71 26.25 26.68 27.07 27.43 27.7 27.9 28.2
Net mobilities, ln, of the peaks in the electropherograms shown in Fig. 1. The analytes are anions, but are recorded at the cationic side of the
separation capillary due to the high electroosmotic ﬂow. Data were corrected by the mobility of the electroosmotic ﬂow. Mobility is in 109
m2 V1 s1. Free virus is indicated by number 0, the numbers, n, of the consecutive peaks follow the sequence with increasing migration time.
Eﬀective mobility of fully saturated complex: 28:16 109 m2 V1 s1. Temperature 20 C. Note that up to number 9 the peaks could be clearly
distinguished. The position of the higher order peaks was estimated.
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expected to only marginally increase from 8.1 MDa for the
virus [20] to 8.2 MDa for a complex containing 12 molecules
of MBP-V33333 (Mr ¼ 67:4 kDa). However, an increase in
the mass cannot account for the diﬀerence in migration since
it rather leads to a reduction of the mobility. We have, thus,
to assume that a signiﬁcant modiﬁcation of the surface charge
of the virus takes place upon receptor binding. This agrees
well with the known involvement of two lysines, Lys1224 and
Lys1228 in the HI loop of VP1, in binding the receptor [12].
The acidic cluster of the receptor module likely neutralizes the
positive charge of these lysines; additionally, the carboxylates
of the strongly acidic entire molecule including MBP (calcu-
lated pI of 4.7) might impart a negative charge to the com-
plex. When a single module covers these two lysines within its
footprint on the viral surface, 24 positive charges should be
lost with a concomitant gain of a number of negative charges.
However, presence of SDS micelles and changes of the hy-
drodynamic diameter of the virus upon receptor binding
preclude an exact theoretical assessment. MBP-V33333 has a
factor Xa cleavage site between the MBP and the concatemer
allowing for separation of MBP from V33333 [9]. When the
same experiments were carried out with V33333, from which
the MBP had been enzymatically removed, the diﬀerent
complexes were not resolved. MBP is, therefore, largely re-
sponsible for the strong modiﬁcation in migrational behavior
in CE.4. Discussion
4.1. Number of receptors bound to the virus at saturation
In the electropherograms of the complexes formed between
MBP-V33333 and HRV2 at low stoichiometric ratio, at least
nine complex peaks can be distinguished (Fig. 1, panel C, see
also the expanded view in Fig. 4). However, from the shape of
the ensemble it is clear that complexes with more than nine
receptors are present. Although higher order peaks cannot be
fully resolved, it is possible to locate approximately their po-
sitions and thus to derive their mobilities. These data are given
in Table 1 together with the eﬀective mobility of the fully
saturated complex (obtained at a 40-fold molar excess of re-
ceptor). The data indicate that the increase in mobility of the
subsequent complexes changes with increasing receptor occu-
pancy in a non-linear fashion down to the fully saturated
complex. To assess the number of receptors bound at satura-
tion, the diﬀerences between the net mobilities of the individual
complexes to that of the saturated complex were plotted as a
function of the peak number (Fig. 2). According to this ap-
proach, peak number 12 indeed approximates the net mobility
of the saturated complex. This strongly suggests a stoichiom-
etry of 1:12 in the virus–receptor complex upon occupation of
all 12 vertices of the icosahedron with receptor. However, we
do not know whether all ﬁve sites around the ﬁvefold axis are
occupied by receptor modules, since the MBP and a number of
amino acid residues that have been introduced between the
Fig. 3. Electropherogram (A) obtained upon complex formation with
the twofold diluted sample (virus concentration 0:34 107 M) com-
pared to the sample shown in Fig. 1D. For both samples, the initial
molar ratio of virus to receptor is 1:2.2. (B) Extended view of trace D
from Fig. 1 for better comparison. EOF: position of the electroosmotic
ﬂow marker. The numbers indicate the occupancy of the virus with 1,
2, 3, etc. receptors. 0: free virus.
Fig. 2. Diﬀerence of net mobility between consecutive peaks and sat-
urated species versus peak number. For numbering of peaks see Fig. 1,
mobilities, see Table 1. Filled squares, clearly recognizable peaks;
empty squares, estimated peaks.
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procedure might result in steric hindrance. This question might
be settled by comparing the binding aﬃnities of MBP-V33333
with that of a construct in which all residues not belonging to
the receptor modules have been removed. Fluorescence reso-
nance energy transfer between a ﬂuorophore attached to the
N-terminus and a ﬂuorophore attached to the C-terminus of
such a construct would also indicate that the receptor adopts a
ring-like structure upon binding to the virus (see Fig. 5).
Fig. 1 shows that the peak corresponding to free receptor
(migrating after the complex) appeared already at virus re-
ceptor ratios that did not result in saturation. This might be
due to the presence of inactive receptor that cannot bind to the
virus. V33333 contains altogether 15 individual disulﬁde bonds
that need to assemble correctly out of the theoretical 6 1015
possibilities. Free receptor would also be present if the equi-
librium association constant were unfavorably low (see below).
Notwithstanding these limitations, the binding stoichiometry
can be determined from the mobilities of the complex peaks as
described (see Fig. 2). This is especially so because from the
geometry of the virus only multiples of 12 need to be consid-
ered (see Fig. 5).
4.2. Equilibrium concentration of the individual complexes
We tried to calculate the theoretical distribution of the
complexes formed between the receptor fragments and the
virus assuming 12 binding sites. For this, an approximate
value for the equilibrium association constants is required. As
the equilibrium is shifted towards the free components when a
twofold diluted sample containing virus and receptor at a
molar ratio of 1:2.2 (compare Fig. 3A and B) is analyzed, it
becomes clear that the complex constant must lay within the
high nanomolar range, as are the concentrations of the re-
actants. It should also be mentioned that, due to partial
dissociation of the complexes in the mixture, the determina-
tion of the stoichiometry by the usual binding curves would
be erroneous. This might be overcome by using higher con-
centrations of the reactants; however, this was not possible
due to limitations in sample preparation and solubility of the
components.Complex formation between soluble receptors and virus was
allowed to occur in the absence of SDS but the background
electrolyte used for CE separation contained 10 mM SDS. The
detergent was found to be required to avoid extensive adsorp-
tion of the virus to the capillary wall [19] and below 5 mM no
reliable electropherograms were obtained (not shown). Al-
though the complexes are exposed to SDS only for some few
minutes during the analysis, the detergent might compete for
the binding sites during the CE run and thereby prevent re-
association of dissociated complexes. This is possibly the rea-
son for the slight change of the electropherograms as seen upon
reduction of the SDS concentration in the background elec-
trolyte from 10 to 5 mM; this resulted in a marginal decrease of
the peak area of the free virus with a concomitant increase of
the peak areas of the complexes. However, electropherograms
recorded in the presence of SDS at concentrations between 10
and 50 mM were virtually identical (data not shown). For the
reason pointed out above, the aﬃnity constants measured by
CE cannot be considered the ‘‘true’’ values and they might be
diﬀerent when determined by other methods.
To derive the equilibrium concentrations of the individual
complexes, the law of mass action was applied to the equilibria
Fig. 4. Comparison of the CE separation of HRV2-receptor complexes
(upper panel) with the results of a calculation of the distribution of
the species according to Eq. (4) (middle panel). Lower panel, histogram
of the areas of the peaks in the electropherogram shown in the top panel.
Initial molar ratio of virus: receptor is 1:1.5 in the incubation mixture.
First peak (number 0) corresponds to free virus; the following peaks
correspond to complexes with diﬀerent receptor occupancies as indi-
catedby thenumbers.Experimental conditions as inFig. 1.Assumptions
for calculation: virus concentration 1 107 M, receptor concentration
3 107 M. Complex constants for the 12 binding sites decreasing by
1 107 each from K1 ¼ 12 107 M to K12 ¼ 1 107 M.
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tion of complex with one receptor according to Aþ B ¼ AB1
is described by the association constant K1 ¼ ½AB1=½A½B,
whereby the brackets indicate the concentrations at equilib-
rium. The equilibrium concentration of the complex AB1 is
thus ½AB1 ¼ K1  ½A½B.Extending this approach to the general case ABðn1Þ þ
B ¼ ABn, we can formulate accordingly
½ABn ¼ K1K2   Kn  ½A½Bn ¼
Yn
1
Kn
( )
½A½Bn: ð1Þ
Here, we assume that the constants for the formation of the
individual species are not equal. For equal complex constants,
K, the term fQn1 Kng is equal to Kn.
Note that all concentrations in the equations are equilibrium
concentrations. The dependence of [ABn] as a function of the
initial reactant concentrations of virus (A) and of receptor (B)
is obtained as follows. Due to the conservation of mass, the
following equations must be valid
½A ¼ ðAÞ  ½AB1  ½AB2  . . . ½ABk 
¼ ðAÞ 
Xk
1
½ABk ; ð2Þ
½B ¼ ðBÞ  ½AB1  2½AB2  . . . k½ABk 
¼ ðBÞ 
Xk
1
k½ABk ; ð3Þ
where k is the number of receptor binding sites, in our case we
assume 12.
The concentration of the individual species as a function of
Kn, and the initial concentrations (A) and (B) are thus:
½ABn ¼
Yn
1
Kn
( )
ðAÞ X12
1
½ABk 
)
ðBÞ X12
1
k½ABk 
)n
ð4Þ
and the occupancy of n can take the values 1; 2; 3; . . . ; 12.
The concentrations of the individual complexes as a function
of the initial concentrations of virus and receptor, and for
particular complex constants were obtained by using the
software Gepasi [22]. Assuming an identical complex constant
for all reactions failed to match the pattern of the concentra-
tions of the complexes found experimentally, since regardless
of the initial virus – receptor ratios used as an input no max-
imum concentration at a medium occupancy (see Fig. 1C–E)
was obtained.
A distribution closely ﬁtting the experimental data was ob-
tained under the reasonable assumption that the on-rate of the
reaction was decreasing with increasing occupancy, since the
probability of collision that leads to a binding event is de-
creased. This means that the individual equilibrium state is
entropically determined (it is reasonable that the enthalpy of
binding to the individual independent sites is most probably
equal, since their distance on the viral surface excludes steric
hindrance; see Fig. 5). The entropy is related to the probability
of each state being realized, which is connected to the number
of free sites on the virus surface. This number is 12 for free
virus and decreases by one for each consecutively bound re-
ceptor. This means that the probability decreases from 12/12 to
1/12 and the entropy increases proportional to lnð1=12Þ for
each step. Consequently, the binding constants decrease by 1/
12 of K1 for each consecutive complex. Based on this postu-
lation, calculations were carried out and in the example shown
below K1 was set to 12 107 M with the constants decreasing
by 1 107 M for each of the higher order complexes (K2 is
thus 11 107 M, K3 is 10 107 M, etc.). The initial virus
Fig. 5. Model of HRV2–receptor complexes. Space ﬁlling representa-
tion of the complex between V23 and HRV2 as deduced from the X-
ray structure (12). Left panel: ﬁve single V3 modules (red) are attached
to the ﬁve symmetry related sites at the 12 vertices of the icosahedral
viral capsid interacting exclusively with VP1 (blue). This results in 60
modules attached in total. Note the possibility of simultaneous at-
tachment of V2 and V3, since the occupancy is only 80% (12). Upon
concatenation, ﬁve modules within a single molecule could adopt a
similar structure but with only 12 molecules bound per virion. In this
arrangement, the MBP and the hexa-his tag (his) are predicted to come
close to each other as schematized in the right panel. One of the 12
pentamers making up the viral capsid is indicated with a thick line.
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out for a threefold molar excess of receptor over virus.
The distribution of the concentrations of the complexes
obtained under these circumstances is shown in Fig. 4, middle
panel. It can be seen that non-reacted virus (indicated by 0) is
still present, and the histogram has a maximum at an occu-
pancy of n ¼ 2, then it falls oﬀ with a complex containing 10
receptors which are still recognizable. This distribution rather
closely resembles that experimentally obtained with a receptor
excess of 1.5. Taking into account the complexity of this virus–
receptor system and the rough approximation of the values
used in the calculation, we believe that the agreement between
experiment and calculation is remarkable.
As suggested by the structure of the complex between V23
and HRV2 solved by X-ray crystallography (Fig. 5), we have
presented evidence that a concatemer of ﬁve consecutive copies
of repeat 3 of the VLDL-receptor can attach to the 12 vertices
of the icosahedral capsid of human rhinovirus serotype 2. This
most probably results in a ring-like structure wound around
each ﬁvefold axis as schematized in Fig. 5. In this arrangement
more than one and possibly all ﬁve modules of a single mol-
ecule attach simultaneously to the virus. Similarly, the natural
receptors LDLR, VLDLR, and LRP might contribute with
up to ﬁve modules to virus binding giving rise to a similar
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